Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.

Epeldegui M, Martínez-Maza O.

For Immunopathol Dis Therap. 2015;6(1-2):79-90. doi: 10.1615/ForumImmunDisTher.2016014177.

2.

Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.

Silas OA, Achenbach CJ, Hou L, Murphy RL, Egesie JO, Sagay SA, Agbaji OO, Agaba PE, Musa J, Manasseh AN, Jatau ED, Dauda AM, Akanbi MO, Mandong BM.

Infect Agent Cancer. 2017 Jun 5;12:34. doi: 10.1186/s13027-017-0144-7. eCollection 2017. Erratum in: Infect Agent Cancer. 2017 Jun 26;12 :37.

3.

Lung Malignancies in HIV Infection.

Sigel K, Pitts R, Crothers K.

Semin Respir Crit Care Med. 2016 Apr;37(2):267-76. doi: 10.1055/s-0036-1578803. Epub 2016 Mar 14. Review.

4.

Cancers in Australia in 2010 attributable to infectious agents.

Antonsson A, Wilson LF, Kendall BJ, Bain CJ, Whiteman DC, Neale RE.

Aust N Z J Public Health. 2015 Oct;39(5):446-51. doi: 10.1111/1753-6405.12445.

5.

Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).

Epeldegui M, Lee JY, Martínez AC, Widney DP, Magpantay LI, Regidor D, Mitsuyasu R, Sparano JA, Ambinder RF, Martínez-Maza O.

Clin Cancer Res. 2016 Jan 15;22(2):328-36. doi: 10.1158/1078-0432.CCR-14-0466. Epub 2015 Sep 17.

6.

Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.

Stier EA, Sebring MC, Mendez AE, Ba FS, Trimble DD, Chiao EY.

Am J Obstet Gynecol. 2015 Sep;213(3):278-309. doi: 10.1016/j.ajog.2015.03.034. Epub 2015 Mar 19. Review.

7.

Factors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era.

Patel P, Armon C, Chmiel JS, Brooks JT, Buchacz K, Wood K, Novak RM.

Open Forum Infect Dis. 2014 May 27;1(1):ofu012. doi: 10.1093/ofid/ofu012. eCollection 2014 Mar.

8.

Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men.

Luu HN, Amirian ES, Chiao EY, Scheurer ME.

Cancer Med. 2014 Dec;3(6):1635-43. doi: 10.1002/cam4.312. Epub 2014 Aug 20.

9.

Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies.

Olsen CM, Knight LL, Green AC.

PLoS One. 2014 Apr 16;9(4):e95096. doi: 10.1371/journal.pone.0095096. eCollection 2014. Review.

10.

TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis.

Guo Y, Siewe B, Epeldegui M, Detels R, Landay AL, Martínez-Maza O.

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):204-10. doi: 10.1097/QAI.0b013e31829d4d50.

11.

The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.

Gingo MR, Balasubramani GK, Kingsley L, Rinaldo CR Jr, Alden CB, Detels R, Greenblatt RM, Hessol NA, Holman S, Huang L, Kleerup EC, Phair J, Sutton SH, Seaberg EC, Margolick JB, Wisniewski SR, Morris A.

PLoS One. 2013;8(3):e58812. doi: 10.1371/journal.pone.0058812. Epub 2013 Mar 12.

12.

Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings.

Semeere AS, Busakhala N, Martin JN.

Curr Opin Oncol. 2012 Sep;24(5):522-30. doi: 10.1097/CCO.0b013e328355e14b. Review.

13.

Impact of HIV Infection on Medicare Beneficiaries with Lung Cancer.

Lee JY, Moore PC, Lensing SY.

J Cancer Epidemiol. 2012;2012:706469. doi: 10.1155/2012/706469. Epub 2012 Apr 3.

14.

HIV as an independent risk factor for incident lung cancer.

Sigel K, Wisnivesky J, Gordon K, Dubrow R, Justice A, Brown ST, Goulet J, Butt AA, Crystal S, Rimland D, Rodriguez-Barradas M, Gibert C, Park LS, Crothers K.

AIDS. 2012 May 15;26(8):1017-25. doi: 10.1097/QAD.0b013e328352d1ad.

15.

11. Cancers attributable to infection in the UK in 2010.

Parkin DM.

Br J Cancer. 2011 Dec 6;105 Suppl 2:S49-56. doi: 10.1038/bjc.2011.484. No abstract available.

16.

HIV infection, immunodeficiency, viral replication, and the risk of cancer.

Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Dubrow R, Quesenberry CP Jr, Neugebauer RS, Abrams DI.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2551-9. doi: 10.1158/1055-9965.EPI-11-0777. Epub 2011 Nov 22.

17.

Effects of long-term use of antiretroviral therapy on the prevalence of oral Epstein-Barr virus.

Amornthatree K, Sriplung H, Mitarnun W, Nittayananta W.

J Oral Pathol Med. 2012 Mar;41(3):249-54. doi: 10.1111/j.1600-0714.2011.01089.x. Epub 2011 Oct 8.

18.

Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk.

Beachler DC, Gellert LL, Jacobson LP, Ambinder RF, Breen EC, Martínez-Maza O, Rabkin CS, Kaslow RA, D'Souza G.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):188-92. doi: 10.1097/QAI.0b013e3181ff976b. Erratum in: J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):e103. Rabkin, Charles C [corrected to Rabkin, Charles S].

19.

Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.

Seaberg EC, Wiley D, Martínez-Maza O, Chmiel JS, Kingsley L, Tang Y, Margolick JB, Jacobson LP; Multicenter AIDS Cohort Study (MACS).

Cancer. 2010 Dec 1;116(23):5507-16. doi: 10.1002/cncr.25530. Epub 2010 Jul 29.

20.

HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study.

Levine AM, Seaberg EC, Hessol NA, Preston-Martin S, Silver S, Cohen MH, Anastos K, Minkoff H, Orenstein J, Dominguez G, Watts DH.

J Clin Oncol. 2010 Mar 20;28(9):1514-9. doi: 10.1200/JCO.2009.25.6149. Epub 2010 Feb 22.

Supplemental Content

Support Center